Paper16613552
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.
Sokoloff P and 6 others. CNS Neurol Disord Drug Targets, 2006. Cited by 263 papers, by iCite.
Cite this record
ConductScience Library. The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. Papers, record 16613552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16613552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Mental Disorders | Major topic |
| Neurons | Major topic |
| Receptors, Dopamine D3 | Major topic |
| Animals | |
| Antipsychotic Agents | |
| Brain-Derived Neurotrophic Factor | |
| Dopamine Agonists | |
| Dopamine Antagonists | |
| Humans |
Source PubMed
Cited by129
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42366275 | Gαo/z-biased coupling profile of the dopamine D3 receptor. | Commun Biol | 2026 | https://conductscience.org/library/papers/42366275 | PubMed |
| 42205511 | Cariprazine modulates affective and social behaviors through ventral striatal islands of Calleja neurons. | Curr Zool | 2026 | https://conductscience.org/library/papers/42205511 | PubMed |
| 41225661 | How evaluation choices distort the outcome of generative drug discovery. | J Cheminform | 2025 | https://conductscience.org/library/papers/41225661 | PubMed |
| 40113786 | Dopaminergic changes in the subgenual cingulate cortex in dementia with lewy bodies associates with presence of depression. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/40113786 | PubMed |
| 40064751 | Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/40064751 | PubMed |
| 39844554 | Exploring Genetic and Receptor-Based Dopaminergic Strategies for Antidepressant Drug Development. | Curr Gene Ther | 2025 | https://conductscience.org/library/papers/39844554 | PubMed |
| 39679842 | DRD4 Interacts with TGF-β Receptors to Drive Colorectal Cancer Metastasis Independently of Dopamine Signaling Pathway. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39679842 | PubMed |
| 39125882 | Neurotrophins and Their Receptors: BDNF's Role in GABAergic Neurodevelopment and Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125882 | PubMed |
| 38655111 | In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor. | Front Neurosci | 2024 | https://conductscience.org/library/papers/38655111 | PubMed |
| 38421437 | The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38421437 | PubMed |
| 37926241 | The influence of dopamine autoreceptors on temperament and addiction risk. | Neurosci Biobehav Rev | 2023 | https://conductscience.org/library/papers/37926241 | PubMed |
| 37458987 | Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37458987 | PubMed |
| 37205475 | Integrative multi-dimensional characterization of striatal projection neuron heterogeneity in adult brain. | bioRxiv | 2023 | https://conductscience.org/library/papers/37205475 | PubMed |
| 37118057 | Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. | Neuropsychopharmacology | 2023 | https://conductscience.org/library/papers/37118057 | PubMed |
| 36931452 | Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance. | Biol Psychiatry | 2023 | https://conductscience.org/library/papers/36931452 | PubMed |
| 36429467 | Evaluation of the Effect of Cariprazine on Memory and Cognition in Experimental Rodent Models. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36429467 | PubMed |
| 36358422 | Effects of Anti-Parkinsonian Drugs on Verbal Fluency in Patients with Parkinson's Disease: A Network Meta-Analysis. | Brain Sci | 2022 | https://conductscience.org/library/papers/36358422 | PubMed |
| 36291277 | Analysis of Influencing Factors of Apathy in Patients with Parkinson's Disease. | Brain Sci | 2022 | https://conductscience.org/library/papers/36291277 | PubMed |
| 36068471 | Pharmacogenetics of Antipsychotic Treatment in Schizophrenia. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/36068471 | PubMed |
| 36059987 | Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression? | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36059987 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16613552
GET https://conductscience.org/api/papers/v1/16613552/cited_by?page=2